Pulmonx Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $90.5M | $83.8M | $68.7M | $53.7M | $48.4M |
| Cost of revenue | $23.4M | $21.8M | $17.9M | $13.8M | $12.8M |
| Gross profit | $67.1M | $62.0M | $50.8M | $39.9M | $35.6M |
| Selling, general & administrative | $101.3M | $102.1M | $94.6M | $83.1M | $69.9M |
| Research and development | $19.5M | $17.6M | $18.1M | $15.4M | $13.1M |
| Operating expenses | $120.8M | $119.7M | $112.7M | $98.5M | $82.9M |
| Operating income | -$53.7M | -$57.7M | -$61.9M | -$58.6M | -$47.3M |
| Interest expense | $3.2M | $3.5M | $3.2M | $1.1M | $829,000 |
| Pretax income | -$53.4M | -$55.9M | -$60.3M | -$58.6M | -$48.3M |
| Income tax expense | $626,000 | $500,000 | $571,000 | $353,000 | $343,000 |
| Net income | -$54.0M | -$56.4M | -$60.8M | -$58.9M | -$48.7M |
| Balance Sheet | |||||
| Cash and equivalents | $69.8M | $70.9M | $83.5M | $101.7M | $148.5M |
| Current assets | $101.7M | $136.2M | $150.4M | $169.0M | $208.0M |
| Total assets | $129.3M | $162.8M | $177.8M | $193.7M | $235.2M |
| Current liabilities | $20.1M | $24.4M | $23.2M | $18.5M | $17.6M |
| Total liabilities | $75.2M | $77.0M | $59.5M | $39.7M | $41.9M |
| Total debt | $42.5M | — | $45.7M | $22.3M | $19.1M |
| Stockholders' equity | $54.1M | $85.8M | $118.3M | $154.0M | $193.2M |
| Cash Flow Statement | |||||
| Cash from operations | -$32.4M | -$31.5M | -$37.6M | -$45.1M | -$41.4M |
| Depreciation and amortization | $1.1M | $1.1M | $1.4M | $1.4M | $700,000 |
| Stock-based compensation | $21.2M | $23.0M | $22.1M | $16.4M | $10.5M |
| Capital expenditure | $452,000 | $1.4M | $807,000 | $1.3M | $3.7M |
| Free cash flow | -$32.8M | -$33.0M | -$38.4M | -$46.4M | -$45.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Share repurchases | — | — | $0 | $27,000 | $26,000 |
Shares outstanding 42.2M · Free float 85.7%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.